Skip Navigation

Masks Strongly Recommended but Not Required in Maryland, Starting Immediately

Due to the downward trend in respiratory viruses in Maryland, masking is no longer required but remains strongly recommended in Johns Hopkins Medicine clinical locations in Maryland. Read more.

Johns Hopkins inHealth

The Johns Hopkins Precision Medicine Center of Excellence for Lung Cancer

Vision

Enhance the outcomes for lung cancer patients through integrative data-driven approaches that deliver precise diagnosis and personalized treatment.

Mission

Build a learning health system that delivers a comprehensive clinical and molecular understanding of our lung cancer patients to improve their pathways to diagnosis, enable guideline-driven personalized care, and increase access to translational research.

Lung Cancer Research and Precision Medicine

Questions we're asking that inform us on how to best care for patients include:

Molecularly-Matched Therapies

Can we improve outcomes by integrating molecular, pathological, and clinical data to match patients with the best therapies?

hexagon pattern

Novel Predictive Biomarkers

Can we discover novel clinical and biological predictors of response to therapies to tailor treatment?

microscope

Adaptive Treatment Strategies

Can we identify subsets of patients where new therapeutic strategies, beyond existing guidelines, are needed?

clipboard

Clinical Trials

The Lung Cancer Program is dedicated to advancing the care of patients with thoracic cancer by recruiting patients to clinical trials. Beyond providing access to promising new treatments, clinical trials drive the future of lung cancer care through evaluation of safety, efficacy, and translational research.

Patient Care Patient Care for Lung Cancer

Our comprehensive Lung Cancer Program includes multi-disciplinary experts at multiple clinical sites of our National Cancer Institute-designated Comprehensive Cancer Center.

Experts and Clinics

Research Programs

Our Lung Cancer Program integrates collaborative research through the Bloomberg Kimmel Institute for Cancer Immunotherapy, the Cancer Immunology Program, and the Cancer Genetics and Epigenetics Program. Through these collaborations, we pursue translational research to improve our understanding of the molecular determinants of lung cancer therapy response and resistance.

Center Directors

  • Valsamo Anagnostou, M.D., Ph.D.

    • Director, Thoracic Oncology Biorepository
    • Co-Director, Lung Cancer Precision Medicine Center of Excellence
    • Associate Professor of Oncology

  • Joseph Christopher Murray, M.D., Ph.D.

    • Co-Director, Lung Cancer Precision Medicine Center of Excellence
    • Director, UAD Immunotherapy Database
    • Assistant Professor of Oncology
    • Joint Appointment in Medicine

Center Team

Kristen Marrone, M.D.
Assistant Professor, Upper Aerodigestive Department

Patrick Forde, M.D.
Associate Professor, Upper Aerodigestive Department

Robert Scharpf, Ph.D.
Associate Professor, Biostatistics and Bioinformatics

Durrant Barasa, M.B.Ch.B.
Data Research Manager & Analyst

Multidisciplinary Disease Management Team and Collaborators

Josephine Feliciano, M.D.
Associate Professor, Upper Aerodigestive Department

Russell Hales, M.D.
Director, Thoracic Oncology Multidisciplinary Program
Assistant Professor, Radiation Oncology and Molecular Radiation Sciences

Richard Battafarano, M.D.
Regional Director of General Thoracic Surgery
Associate Professor of Surgery

Lonny Yarmus, D.O.
Clinical Director, Division of Pulmonary and Critical Care Medicine
Associate Professor of Medicine

Khinh Ranh Voong, M.D., M.P.H.
Assistant Professor of Radiation Oncology and Molecular Radiation Sciences

Stephen Broderick, M.D.
Associate Director, Johns Hopkins Cardiothoracic Residency Program
Assistant Professor of Surgery